5 Polen Capital Medifast Trades
Polen Capital started to build up the position in Medifast in Q1 2019 and continued to invest until Q4 2019. Since then they sold 5.64 Thousand shares. The investor sold all their shares in Q1 2020 and doesn't own any shares in Medifast anymore.
Avg closing price
Price range
Sold -5.64 Thousand shares
Q1 2020
Avg closing price
$91.04
Price range
$51.98
-
$116.89
Increased shares by 15.9% (+773 shares)
Q4 2019
Avg closing price
$96.78
Price range
$74.36
-
$112.83
Increased shares by 0.4% (+18 shares)
Q3 2019
Avg closing price
$107.48
Price range
$98.06
-
$122.99
Increased shares by 8.7% (+386 shares)
Q2 2019
Avg closing price
$138.92
Price range
$126.41
-
$157.08
New holding (+4.46 Thousand shares)
Q1 2019
Avg closing price
$126.84
Price range
$107.24
-
$136.31
News about Medifast Inc and Polen Capital
Medifast Earnings Perspective: Return On Capital Employed
Pulled from Benzinga Pro data, Medifast (NYSE: MED ) posted Q4 earnings of $26.52 million, an increase from Q3 of 26.65%. Sales dropped to $337.25 million, a...
Medifast''s Return on Invested Capital Insights
Pulled from Benzinga Pro data, Medifast (NYSE: MED ) posted Q3 earnings of $36.16 million, an increase from Q2 of 7.56%. Sales dropped to $390.40 million, a ...